Registration

SIMS STRATEGIES, LLC for GLAXOSMITHKLINE, INC.

Firm
Client
Income
—
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Issues affecting pharmaceuticals in health care and tax

LobbyistCovered position, as disclosed
EDWARD PRETTYMAN New Legislative Correspondent and Constituent Services Representative, Sen. Tom Carper (D-DE)
MICHAELA SIMS New Legislative Counsel, Sen. Ben Nelson (D-NE); Legislative Director and Counsel, Sen. Bob Kerrey (D-NE)

Health Issues HCR

Issues affecting pharmaceuticals in health care and tax

LobbyistCovered position, as disclosed
EDWARD PRETTYMAN New Legislative Correspondent and Constituent Services Representative, Sen. Tom Carper (D-DE)
MICHAELA SIMS New Legislative Counsel, Sen. Ben Nelson (D-NE); Legislative Director and Counsel, Sen. Bob Kerrey (D-NE)

Medicare/Medicaid MMM

Issues affecting pharmaceuticals in health care and tax

LobbyistCovered position, as disclosed
EDWARD PRETTYMAN New Legislative Correspondent and Constituent Services Representative, Sen. Tom Carper (D-DE)
MICHAELA SIMS New Legislative Counsel, Sen. Ben Nelson (D-NE); Legislative Director and Counsel, Sen. Bob Kerrey (D-NE)

Pharmacy PHA

Issues affecting pharmaceuticals in health care and tax

LobbyistCovered position, as disclosed
EDWARD PRETTYMAN New Legislative Correspondent and Constituent Services Representative, Sen. Tom Carper (D-DE)
MICHAELA SIMS New Legislative Counsel, Sen. Ben Nelson (D-NE); Legislative Director and Counsel, Sen. Bob Kerrey (D-NE)

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

EntityCountryPrincipal place of businessOwnershipContribution declared
GLAXOSMITHKLINE, PLC United Kingdom United Kingdom 100.0% —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.